Articles producció científica> Medicina i Cirurgia

Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice

  • Identification data

    Identifier: imarina:2183942
    Handle: http://hdl.handle.net/20.500.11797/imarina2183942
  • Authors:

    Alegret JM, Viñolas X, Romero-Menor C, Pons S, Villuendas R, Calvo N, Pérez-Rodon J, Sabaté X, REVERCAT study investigators
  • Others:

    Author, as appears in the article.: Alegret JM, Viñolas X, Romero-Menor C, Pons S, Villuendas R, Calvo N, Pérez-Rodon J, Sabaté X, REVERCAT study investigators
    Department: Medicina i Cirurgia
    URV's Author/s: Alegret Colomé, Josep Maria
    Keywords: Weight gain Trend study Treatment outcome Time factors Tertiary health care Task-force Spain Sotalol Sinus rhythm Rhythm control Registries Rate control Prospective studies Propafenone Priority journal Prevalence Prescription Practice guidelines as topic Practice guideline Population research Physician's practice patterns Middle aged Management Male Major clinical study Maintenance Humans Human Heart-rhythm-association Heart left ventricle ejection fraction Heart atrium fibrillation Health care utilization Health care surveys Guideline adherence Follow-up Follow up Flecainide Female External cardioversion Evidence-based medicine European-society Embolism Electrical cardioversion Electric countershock Diabetes mellitus Comorbidity Collaboration Chi-square distribution Cardioversion Cardiology committee Atrial fibrillation Article Antiarrhythmic agent Anti-arrhythmia agents Amiodarone American-college Aged Age factors Adult
    Abstract: The purpose of the present study was to assess the trends in the use of ECV following published studies that had compared rhythm and rate control strategies on atrial fibrillation (AF), and the recommendations included in the current clinical practice guidelines.The REVERCAT is a population-based assessment of the use of electrical cardioversion (ECV) in treating persistent AF in Catalonia (Spain). The initial survey was conducted in 2003 and the follow-up in 2010.We observed a decrease of 9% in the absolute numbers of ECV performed (436 in 2003 vs. 397 in 2010). This is equivalent to 27% when considering population increases over this period. The patients treated with ECV in 2010 were younger, had a lower prevalence of previous embolism, a higher prevalence of diabetes, and increased body weight. Underlying heart disease factors indicated, in 2010, a higher proportion of NYHA ? II and left ventricular ejection fraction <30%. We observed a reduction in the number of ECV performed in 16 of the 27 (67%) participating hospitals. However, there was an increase of 14% in the number of procedures performed in tertiary hospitals, and was related to the increasing use of ECV as a bridge to AF ablation. Considering the initial number of patients treated with ECV, the rate of sinus rhythm at 3 months was almost unchanged (58% in 2003 vs. 57% in 2010; p=0.9) despite the greater use of biphasic energy in 2010 and a similar prescription of anti-arrhythmic drugs.Although we observed a decrease in the number of ECVs performed over the 7 year period between the two studies, this technique remains a common option for treating patients with persistent AF. The change in the characteristics of candidate patients did not translate into better outcomes.
    Thematic Areas: Saúde coletiva Psicología Medicina iii Medicina ii Medicina i Matemática / probabilidade e estatística Interdisciplinar Farmacia Educação física Ciências biológicas ii Ciências biológicas i Cardiology and cardiovascular medicine Cardiac & cardiovascular systems Biotecnología
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 14712261
    Author's mail: josepmaria.alegret@urv.cat
    Author identifier: 0000-0002-6117-5512
    Record's date: 2023-02-18
    Papper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/1471-2261-12-42
    Licence document URL: http://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Bmc Cardiovascular Disorders. 12 (): 42-
    APA: Alegret JM, Viñolas X, Romero-Menor C, Pons S, Villuendas R, Calvo N, Pérez-Rodon J, Sabaté X, REVERCAT study investigators (2012). Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice. Bmc Cardiovascular Disorders, 12(), 42-. DOI: 10.1186/1471-2261-12-42
    Article's DOI: 10.1186/1471-2261-12-42
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2012
    Publication Type: Journal Publications
  • Keywords:

    Cardiac & Cardiovascular Systems,Cardiology and Cardiovascular Medicine
    Weight gain
    Trend study
    Treatment outcome
    Time factors
    Tertiary health care
    Task-force
    Spain
    Sotalol
    Sinus rhythm
    Rhythm control
    Registries
    Rate control
    Prospective studies
    Propafenone
    Priority journal
    Prevalence
    Prescription
    Practice guidelines as topic
    Practice guideline
    Population research
    Physician's practice patterns
    Middle aged
    Management
    Male
    Major clinical study
    Maintenance
    Humans
    Human
    Heart-rhythm-association
    Heart left ventricle ejection fraction
    Heart atrium fibrillation
    Health care utilization
    Health care surveys
    Guideline adherence
    Follow-up
    Follow up
    Flecainide
    Female
    External cardioversion
    Evidence-based medicine
    European-society
    Embolism
    Electrical cardioversion
    Electric countershock
    Diabetes mellitus
    Comorbidity
    Collaboration
    Chi-square distribution
    Cardioversion
    Cardiology committee
    Atrial fibrillation
    Article
    Antiarrhythmic agent
    Anti-arrhythmia agents
    Amiodarone
    American-college
    Aged
    Age factors
    Adult
    Saúde coletiva
    Psicología
    Medicina iii
    Medicina ii
    Medicina i
    Matemática / probabilidade e estatística
    Interdisciplinar
    Farmacia
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Cardiology and cardiovascular medicine
    Cardiac & cardiovascular systems
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar